84651-0200 IBTROZI - CanMED: NDC

Product NDC:

84651-0200

Brand Name:

IBTROZI

Generic Name:

Taletrectinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: TALETRECTINIB ADIPATE

Strength: 272.0

Unit: mg/1

Packages:

Code: 84651-0200-93

Description: 3 BOTTLE in 1 CARTON (84651-200-93) / 30 CAPSULE in 1 BOTTLE (84651-200-30)

Effective Date: June 13, 2025

Discontinued:

Code: 84651-0200-90

Description: 1 BOTTLE in 1 CARTON (84651-200-90) / 90 CAPSULE in 1 BOTTLE

Effective Date: Sept. 1, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

ROS1, TRKA, TRKB, TRKC

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox